PPRC1 and lymphoma: We have found that the PPRC1 gene alterations correlate significantly with both short OS and Disease-Free Survival (DFS) in breast cancer (p = 0.0002 and p = 0.02, respectively) (Figure 8A,B), Lymphoma (p = 0.0006 and p = 0.016, respectively) (Figure 8C,D), Uterus (p = 0.0006 and p = 0.0452, respectively) (copy number mutations only) (Figure 8E,F) and short OS in Pancreas (p = 0.0001) (Figure 8G) and Liver (p = 0.01) (Figure 8H).